Lassman AB, Pugh SL, Wang TJC, Aldape K, et al. Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. Neuro Oncol 2022 Jul 15. pii: 6645128. doi: 10.1093.
PMID: 35849035